Publikationen von 0000-0003-0855-6495
(ORCID: 0000-0003-0855-6495)

Stupp, Roger, Hegi, Monika E , Gorlia, Thierry, Erridge, Sara C, Perry, James, Hong, Yong-Kil, Aldape, Kenneth D, Lhermitte, Benoit, Pietsch, Torsten, Grujicic, Danica, Steinbach, Joachim Peter, Wick, Wolfgang, Tarnawski, Rafał, Nam, Do-Hyun, Hau, Peter, Weyerbrock, Astrid, Taphoorn, Martin J B, Shen, Chiung-Chyi, Rao, Nalini, Thurzo, László, Herrlinger, Ulrich, Gupta, Tejpal, Kortmann, Rolf-Dieter, Adamska, Krystyna, McBain, Catherine, Brandes, Alba A, Tonn, Joerg Christian, Schnell, Oliver, Wiegel, Thomas, Kim, Chae-Yong, Nabors, Louis Burt , Reardon, David A, van den Bent, Martin J , Hicking, Christine, Markivskyy, Andriy, Picard, Martin und Weller, Michael (2014) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology 15 (10), S. 1100-1108. Volltext nicht vorhanden.

Stupp, Roger, Hegi, Monika E. , Mason, Warren P., van den Bent, Martin J. , Taphoorn, Martin J. B., Janzer, Robert C., Ludwin, Samuel K., Allgeier, Anouk, Fisher, Barbara, Belanger, Karl, Hau, Peter, Brandes, Alba A. , Gijtenbeek, Johanna, Marosi, Christine, Vecht, Charles J., Mokhtari, Karima, Wesseling, Pieter , Villa, Salvador , Eisenhauer, Elizabeth, Gorlia, Thierry, Weller, Michael, Lacombe, Denis, Cairncross, J. Gregory und Mirimanoff, René-Olivier (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The lancet oncology 10 (5), S. 459-466. Volltext nicht vorhanden.

Beier, Christoph P., Schmid, Christina, Gorlia, Thierry, Kleinletzenberger, Christine, Beier, Dagmar, Grauer, Oliver, Steinbrecher, Andreas, Hirschmann, Birgit, Brawanski, Alexander, Dietmaier, Christopher, Jauch-Worley, Tanja, Kölbl, Oliver, Pietsch, Torsten, Proescholdt, Martin A., Rümmele, Petra, Muigg, Armin, Stockhammer, Günther, Hegi, Monika , Bogdahn, Ulrich und Hau, Peter (2009) RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. BMC cancer 9, S. 308.

Hau, Peter, Stupp, Roger und Hegi, Monika E. (2007) MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma? Disease Markers 23 (1-2), S. 97-104. Volltext nicht vorhanden.

Hegi, Monika E. , Diserens, Annie-Claire, Gorlia, Thierry, Hamou, Marie-France, de Tribolet, Nicolas, Weller, Michael, Kros, Johan M., Hainfellner, Johannes A., Mason, Warren, Mariani, Luigi, Bromberg, Jacoline E. C., Hau, Peter, Mirimanoff, René O., Cairncross, J. Gregory, Janzer, Robert C. und Stupp, Roger (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. The New England journal of medicine 352 (10), S. 997-1003. Volltext nicht vorhanden.